Home › Ulcerative Colitis › Texas › Houston
Ulcerative Colitis clinical trials in Houston, TX
17 studies for Ulcerative Colitis are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- Integrity Advanced Therapeutics /ID# 283871, Houston
- Novel Research - Bellaire /ID# 280925, Bellaire · 7 mi away
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RecruitingPhase 4
- Kelsey Research Foundation, Houston
- MedCare Pharma LLC, Houston
- Spring Clinical Research, Houston
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Baylor College of Medicine, Houston
- Intergrity Research, Houston
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
RecruitingPhase 1/2Healthy volunteers welcome
- Xencor Investigative Site, Houston
- Xencor Investigative Site, Houston
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Site US-030, Houston
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- Victorium Clinical Research, Houston
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
RecruitingPhase 2/3
- Texas Children's Hospital, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- UT MD Anderson Cancer Center, Houston
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Integrity Advanced Therapeutics, Houston
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RecruitingPhase 4
- The University of Texas Health Science Center at Houston, Houston
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
RecruitingObservational study
- BAMC, Houston
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
RecruitingPhase 2
- Baylor College of Medicine, Houston
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Recruiting
- Baylor College of Medicine, Houston
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RecruitingObservational study
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RecruitingObservational study
- M D Anderson Cancer Center, Houston
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RecruitingPhase 3
- Texas Children's Hospital - Baylor - PIN, Houston
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, Houston
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- New York City, NY23 studies
- Orlando, FL22 studies
- Miami, FL21 studies
- San Antonio, TX16 studies
- Tacoma, WA15 studies
- Chicago, IL15 studies
- San Diego, CA15 studies
- Tyler, TX14 studies
- Colorado Springs, CO14 studies
- Los Angeles, CA13 studies
- St. Louis, MO13 studies
- Washington, DC12 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.